US Patent Application 20100028383 - Chemically defined stabiliser
Inventors
AssigneeUS Classes424/209.1, Orthomyxoviridae (e.g., influenza virus, fowl plague virus, etc.)514/773, Peptide containing424/184.1, ANTIGEN, EPITOPE, OR OTHER IMMUNOSPECIFIC IMMUNOEFFECTOR (E.G., IMMUNOSPECIFIC VACCINE, IMMUNOSPECIFIC STIMULATOR OF CELL-MEDIATED IMMUNITY, IMMUNOSPECIFIC TOLEROGEN, IMMUNOSPECIFIC IMMUNOSUPPRESSOR, ETC.)424/234.1, Bacterium or component thereof or substance produced by said bacterium (e.g., Legionella, Borrelia, Anaplasma, Shigella, etc.)424/204.1, Virus or component thereof424/229.1, Herpetoviridae (e.g., herpesvirus, Marek`s disease virus, laryngotracheitis virus, infectious bovine rhinotracheitis virus (IBR), infectious pustular vulvovaginitis virus, bovine herpes virus type 1, Aujeszky`s disease virus, feline rhinotracheitis virus, feline herpes virus, etc.)424/211.1, Paramyxoviridae (e.g., parainfluenza virus, respiratory syncytial virus, rinderpest virus, Sendai virus, canine tracheobronchitis virus, turkey rhinotracheitis virus, etc.)424/233.1, Adenoviridae, adeno-like virus, or Parvoviridae (e.g., adenovirus, canine parvovirus, mink enteritis virus, hemorrhagic enteritis virus, feline panleukopenia virus, egg drop syndrome virus, etc.)424/224.1, Rhabdoviridae (e.g., rabies virus, vesicular stomatitis virus, etc.)424/221.1, Coronaviridae (e.g., neonatal calf diarrhea virus, feline infectious peritonitis virus, canine coronavirus, etc.)424/232.1Poxviridae (e.g., smallpox virus, avian pox virus, fowlpox virus, rabbit myxoma virus, vaccinia virus, etc.)Attorney, Agent or FirmForeign Documents
International ClassesA61K 47/42A61K 39/00 A61K 39/02 A61K 39/12 A61K 39/245 A61K 39/155 A61K 39/145 A61K 39/235 A61K 39/205 A61K 39/215 A61K 39/275 A61P 31/04 A61P 31/12 Abstract textThe present invention relates to a stabiliser composition comprising an amino acid, and a sugar wherein all compounds are chemically defined; to a vaccine composition comprising such a stabiliser composition and a biological molecule and/or a micro-organism; to a method for preparing a pharmaceutical composition comprising admixing such a stabiliser composition with a biological molecule and/or a micro-organism; to the use of such a stabiliser composition, and of vaccines prepared therewith. |
| ||||||||||||||
